Why Kamet
Stop buying services. Start getting solutions.
Traditional consultancies sell hours. They create dependency, not change. Kamet replaces services with solutions engineered for life sciences — execution-ready and designed to leave lasting impact.
What Makes Us Different
Five reasons teams choose Kamet over traditional firms.
Solutions over services
Outcomes you can own, not hours you must rebuy. We deliver systems, processes, and trained teams — not slide decks.
Execution at scale
Turning enterprise complexity into aligned delivery across regulatory, quality, supply chain, manufacturing, commercial, and labeling.
Expertise meets automation
Regulatory, PV, quality, and compliance advice you can act on — engineered into processes and workflows, not trapped in presentations.
Seamless transitions
High-stakes M&A, divestitures, and tech transfers without loss of continuity, compliance, or patient safety.
Capability building
We build your team's ability to operate independently. Every engagement is designed to reduce dependency, not increase it.
Practitioner-led
Our team has operated inside the programs we advise on — $14B spin-offs, $63B integrations, FDA submissions. We've done the work, not just studied it.
How We Work
A fundamentally different consulting model.
We don't bill by the hour — we build systems that outlast the engagement.
Traditional Model
Hour-based billing creates dependency
Slide decks without execution
Manual processes remain manual
Knowledge walks out with consultants
Recurring costs, recurring problems
The Kamet Model
Outcome-based delivery with clear metrics
Production-grade execution, not presentations
Systems and processes that outlast the engagement
Knowledge embedded in workflows and teams
Capability building that reduces dependency
Proof It Works
Our model changes how organizations operate.
In large-scale transformations, we've replaced manual planning with structured execution that reduces risk and shortens delivery by months. In acquisitions, we've safeguarded product continuity through transitions that would otherwise stall markets.
100+
Countries Aligned
Global Rebranding Program
$14B Global Healthcare Spin-Off
Strategic regulatory planning for a global rebranding across 100+ markets and 45,000 SKUs, aligning cross-functional teams under aggressive trademark exit timelines.
Download Case Study10K+
Labels Delivered
Labeling Operations & Redlines
$14B Global Healthcare Spin-Off
Executed 10,000+ compliant, inspection-ready label redlines across medical device portfolios, capturing rebranding and MDR regulatory changes.
Download Case Study40%
Faster Planning
Global Regulatory Transformation
Top-10 Biopharma
Redesigned submissions operating model. Standardized SOPs and governance across global teams.
Download Case StudyReady for consulting that actually delivers?
Tell us about your challenge. We'll tell you exactly how we'd approach it.
Start the Conversation